Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →

APPLICATOR, SILVER NITR

Active
SPE2DP-26-T-4199Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The applicator consists of a topical medical device containing a fused mixture of 75% silver nitrate and 25% potassium nitrate, with each applicator measuring six inches in length. It is restricted to prescription use only and packaged in containers of 100 units. Storage requires keeping the product in its original closed container at room temperature in a dark, dry location away from organic or oxidizable materials. The item is regulated by the FDA and subject to a 24-month non-extendable shelf life under TYPE I (CODE M) requirements. Hazardous materials protocols apply, mandating submission of a current Material Safety Data Sheet (MSDS) to DLA.MSDS@DLA.MIL and physical inclusion of the MSDS with every shipment, with packaging conforming to SPE2DP-26-T-4199 and applicable 49 CFR and ICAO standards. The NSN is 6505-00-299-9672, and the solicitation number is SPE2DP-26-T-4199, issued by the Department of Defense under the Medical Supply Chain Pharm FSA, with a response deadline of July 27, 2026, and a required delivery within five days of award. The contracting official must submit an EBS referral for FDA confirmation, including bidder and manufacturer details. Covered defense information requirements and removal of government identification from non-accepted supplies also apply.

General Info

Prescription silver nitrate applicator, FDA-regulated, 24-month shelf life, MSDS required, DLA shipment compliance, NSN 6505-00-299-9672.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

ATTN: SSN 801, GROTON, CT, 06340-4905, US

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-4199 Medical Supply Chain Pharma FSA

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts

Full Description

Show more
APPLICATOR,SILVER NITRATE
APPLICATOR, SILVER NITRATE. RX ONLY, FOR TOPICAL USE. EACH APPLICATOR
CONSISTS OF A MIXTURE OF 75% SILVTER NITRATE AND 25% POTASSIUM NITRATE
FUSED TO ONE END THAT MEASURES 6 INCHES OR 1.524 CENTIMETERS (CM). UNIT
OF ISSUE IS A CONTAINER CONTAINING 100 EACH (APPLICATORS). STORE IN THE
CLOSED PACKAGE AT ROOM TEMPERATURE IN A DARK, DRY LOCATION, AWAY FROM
ORGANIC OR OTHER READILY OXIDIZABLE MATERIALS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
RQ034: HAZARDOUS COMMUNICATION STANDARD NOTICE
.
HAZARDOUS MATERIALS REQUIREMENTS.
.
MATERIAL SAFETY DATA SHEET (MSDS).
.
. A CURRENT MSDS SHALL BE PROVIDED FOR THIS
ITEM. DLA'S DOD HMIRS FOCAL POINT (VBA) HAS
ESTABLISHED AN ELECTRONIC MAILBOX TO WHICH
ONE CAN TRANSMIT THE MSDS, TOGETHER WITH THE
COVER SHEET (P-75) WHOSE CONTENTS ARE TO
REFLECT LOGISTICS INFORMATION PROPER TO THE
MSDS ASSOCIATED WITH THE AWARDED CONTRACT AND
NSN. THE ELECTRONIC MAILBOX ADDRESS IS
DLA.MSDS@DLA.MIL.
.
. IN ADDITION, A COPY OF THE MSDS SHALL
ACCOMPANY EACH SHIPMENT OF THIS ITEM.
.
PACKAGING.
.
. PACKAGING FOR HAZARDOUS MATERIALS SHALL
COMPLY WITH APPLICABLE REGULATIONS, I.E.,
SPE2DP-26-T-4199
SECTION B
49 CFR, INTERNATIONAL CIVIL AVIATION
ORGANIZATION (ICAO) TECHNICAL NSN/Part Number: 6505-00-299-9672 Quantity: 1 CO Purchase Request: 7017530564QTY: 1 Delivery: 5 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
Medical Chemical Formulation and ManufacturingThe contract involves the manufacture of a modified 0.125 percent sodium hypochlorite solution, known as Dakins Solution Quarter Strength, packaged in 480 mL bottles. The scope includes full formulation development, rigorous quality control protocols, batch-by-batch testing to ensure consistency and safety, and strict compliance with medical-grade standards to meet regulatory requirements for clinical use. All production activities must adhere to guidelines ensuring sterility, stability, and purity, as the final product is intended for medical applications requiring precise chemical concentrations and contamination-free packaging. The contract is classified as a subcontract under NAICS code 325412 for pharmaceutical and medicine manufacturing, issued by the Department of Defense through the Medical Supply Chain Pharm FSA. It was posted on July 20, 2026, with a response deadline of July 27, 2026, and the performance location is not specified, implying flexibility in manufacturing site selection as long as compliance and delivery standards are met. The solicitation is accessible through the DIBBS platform, and while no set-aside provisions or point of contact information is provided, bidders are expected to demonstrate proven capability in producing pharmaceutical-grade chemical solutions with validated quality systems and documented adherence to medical manufacturing regulations.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 13 hours ago

DEADLINE

in 6 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency